A case of ketamine dependence

Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.

Øye, I., Paulsen, O., & Maurset, A. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11430-4 · Cited by 434 · see citing works

Ketamine–Can Chronic Use Impair Memory

Jansen, K. L. R. (1990) · International Journal of the Addictions · doi:10.3109/10826089009056204 · Cited by 67 · see citing works

Ketamine use: a review

Morgan, C. J. A., Curran, H. V., & the Independent Scientific Committee on Drugs (ISCD) (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03576.x · Cited by 667 · see citing works

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism

Williams, N. R., Heifets, B. D., Blasey, C., Sudheimer, K., Pannu, J., Pankow, H., Hawkins, J., Birnbaum, J., Lyons, D. M., Rodriguez, C. I., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18020138 · Cited by 519 · see citing works

Acute and chronic effects of ketamine upon human memory: a review

Morgan, C. J. A., & Curran, H. V. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0572-3 · Cited by 304 · see citing works

Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications

Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265 · see citing works

Patterns of use and harms associated with non-medical ketamine use

Dillon, P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00243-0 · Cited by 245 · see citing works

A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences

Jansen, K. L. R. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400244 · Cited by 229 · see citing works

Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate

Smith, K. M., Larive, L. L., & Romanelli, F. (2002) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/59.11.1067 · Cited by 225 · see citing works

Ketamine

Wolff, K., & WINSTOCK, A. R. (2006) · CNS Drugs · doi:10.2165/00023210-200620030-00003 · Cited by 209 · see citing works

The Nonmedical Use of Ketamlne, Part Two: A Review of Problent Use and Dependence

Jansen, K. L. R., & Darracot-Cankovic, R. (2001) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2001.10400480 · Cited by 137 · see citing works

Illicit Use of Ketamine in Scotland

Dalgarno, P., & Shewan, D. (1996) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1996.10524391 · Cited by 133 · see citing works

Recent Trends in the Use of “Club Drugs”: An Australian Review

Degenhardt, L. J., Copeland, J., & Dillon, P. (2005) · Substance Use & Misuse · doi:10.1081/ja-200066777 · Cited by 114 · see citing works

Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose?response study

Morgan, C. J. A., Mofeez, A., Brandner, B., Bromley, L. M., & Curran, H. V. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1656-y · Cited by 106 · see citing works

Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development

Lerner, A., & Klein, M. (2019) · Brain Communications · doi:10.1093/braincomms/fcz025 · Cited by 89 · see citing works

Gender differences in subjective discontinuation symptoms associated with ketamine use

Chen, W.-Y., Huang, M.-C., & Lin, S.-K. (2014) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/1747-597x-9-39 · Cited by 87 · see citing works

Potential Human Neurotoxicity of MDMA (‘Ecstasy’): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies

Schifano, F. (2000) · Neuropsychobiology · doi:10.1159/000026667 · Cited by 83 · see citing works

A case of ketamine dependence with discontinuation symptoms

Critchlow, D. G. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01494.x · Cited by 79 · see citing works

Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder

Kryst, J., Kawalec, P., & Pilc, A. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1683161 · Cited by 78 · see citing works

Attentional bias to incentive stimuli in frequent ketamine users

Morgan, C. J. A., Rees, H., & Curran, H. V. (2008) · Psychological Medicine · doi:10.1017/s0033291707002450 · Cited by 76 · see citing works

Ketamine Dependence in Anesthesia Providers

Moore, N. N., & Bostwick, J. M. (1999) · Psychosomatics · doi:10.1016/s0033-3182(99)71231-4 · Cited by 70 · see citing works

Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant

Kokane, S. S., Armant, R. J., Bolaños‐Guzmán, C. A., & Perrotti, L. I. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112548 · Cited by 62 · see citing works

The health and psycho-social consequences of ketamine use

Copeland, J., & Dillon, P. (2005) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2004.12.003 · Cited by 55 · see citing works

Ketamine Psychedelic Psychotherapy: Focus on its Pharmacology, Phenomenology, and Clinical Applications

Kolp, E., Friedman, H. L., Krupitsky, E. M., Jansen, K., Sylvester, M., Young, M. S., & Kolp, A. (2014) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2014.33.2.84 · Cited by 58 · see citing works

Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.

Abdulrahim, D., & Bowden‐Jones, O. (2015) · Cited by 46 · see citing works

Postmortem Blood Ketamine Distribution in Two Fatalities

Lalonde, B. R., & Wallage, H. R. (2004) · Journal of Analytical Toxicology · doi:10.1093/jat/28.1.71 · Cited by 45 · see citing works

Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing

Swainson, J., Klassen, L. J., Brennan, S., Chokka, P. R., Katzman, M. A., Tanguay, R. L., & Khullar, A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00897-2 · Cited by 47 · see citing works

1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances

Wallach, J. V., & Brandt, S. D. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_148 · Cited by 42 · see citing works

Histoire de la kétamine : une molécule ancienne qui a toujours la cote

Daré, B. L., Pelletier, R., Morel, I., & Gicquel, T. (2021) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2021.04.005 · Cited by 24 · see citing works

Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment

Barrios, K. P., Connolly, D. J., Ferris, J., Maier, L. J., Barratt, M. J., WINSTOCK, A. R., Puljević, C., & Gilchrist, G. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241273850 · Cited by 19 · see citing works

Safety and efficacy of intranasal ketamine in a mixed population with chronic pain

Carr, D. B., Goudas, L. C., Denman, W. T., Brookoff, D., Lavin, P. T., & Staats, P. S. (2004) · Pain · doi:10.1016/j.pain.2004.04.014 · Cited by 18 · see citing works

Reliability and validity of the Severity of Dependence Scale in a Chinese sample of treatment-seeking ketamine users.

Tung, C.-K., Yeung, S. W., Chiang, T. P., Xu, K., & Lam, M. W. C. (2014) · PubMed · Cited by 14 · see citing works

Genotoxic effects of N-nitrosoketamine and ketamine as assessed by in vitro micronucleus test in Chinese hamster lung fibroblast cell line

Toyama, Y., Shimizu, H., Suzuki, Y., Miyakoshi, Y., & Yoshioka, H. (2006) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.11.120 · Cited by 14 · see citing works

KETAMINE - REVES ET REALITES

Arditti, J., Spadari, M., de Haro, L., Brun, A., Jh, B., & Valli, M. (2002) · Acta Clinica Belgica · doi:10.1179/acb.2002.073 · Cited by 12 · see citing works

Psychological Treatments of Substance Misuse and Dependence

Curran, H. V., & Drummond, C. (2007) · Elsevier eBooks · doi:10.1016/b978-012370624-9/50010-4 · Cited by 10 · see citing works

Clinical Outcome of Augmentation Enterocystoplasty for Patients with Ketamine-induced Cystitis

Kuo, H. (2017) · Pain Physician · doi:10.36076/ppj.2017.e436 · Cited by 11 · see citing works

Arylcyclohexamines (Ketamine, Phencyclidine, and Analogues)

Ho, J. H., & Dargan, P. I. (2016) · Springer eBooks · doi:10.1007/978-3-319-20790-2_124-1 · Cited by 8 · see citing works

Ketamine Abuse: Past and Present

Huang, M., & Lin, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-2902-3_1 · Cited by 8 · see citing works

Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review

Veraart, J. K. E., Schimmers, N., Breeksema, J. J., Seybert, C., Kamphuis, J., Huber, L. F. T., Rota, A., Coerts, D. T., Oliveira-Maia, A. J., & Schoevers, R. A. (2026) · Clinical Psychology Review · doi:10.1016/j.cpr.2026.102706 · Cited by 7 · see citing works

Ketamina: Nuevas observaciones sobre su consumo, consumidores y efectos

Jansen, K. L. R., & Theron, L. (2003) · Adicciones · doi:10.20882/adicciones.458 · Cited by 6 · see citing works

Ketamine

Wolff, K. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_15 · Cited by 3 · see citing works

Arylcyclohexamines: Ketamine, Phencyclidine, and Analogues

Ho, J. H., & Dargan, P. I. (2017) · Springer eBooks · doi:10.1007/978-3-319-17900-1_124 · Cited by 3 · see citing works

Arylcyclohexamines: Ketamine, Phencyclidine, and Analogues

Ho, J. H., & Dargan, P. I. (2018) · Springer eBooks · doi:10.1007/978-3-319-20790-2_124-2 · Cited by 2 · see citing works

Ketamine

Li, Q., Chan, W. M., Rudd, J. A., Wang, C. M., Lam, P. Y. H., Wai, M. S. M., Wood, D. M., Dargan, P. I., & Yew, D. T. W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415816-0.00012-2 · Cited by 1 · see citing works

Comments on "The ketamine model of the near-death experience: A central role for the N-methyl-D-aspartate receptor".

Bianchi, A. (1997) · The Journal of near-death studies · doi:10.17514/jnds-1997-16-1-p71-78 · Cited by 1 · see citing works

Addiction and treatment of novel psychoactive substance dependence

Abdulrahim, D., & Bowden‐Jones, O. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818788-3.00005-x · Cited by 1 · see citing works

Arylcyclohexamines

Salter, M. D., & Gunja, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818788-3.00011-5 · Cited by 1 · see citing works

ACMDCouncil on the Misuse of Drugs

Sulaiman, Z., Street, M., & Featherstone, L. (2014)

Ketamine

Barceloux, D. G. (2012) · Wiley eBooks · doi:10.1002/9781118105955.ch7

Arylcyclohexamine type drugs

Warriner, M. J., Dargan, P. I., & Wood, D. M. (2024) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2024.11.016

[Ketamine dependence].

Rusek, A., Matkowski, J., & Matysiakiewicz, J. A. (1988) · PubMed

A case of ketamine dependence with discontinuation symptoms

Critchlow, D. G. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01494.x · Cited by 79 · see citing works

Ketamine Dependence: Case Report and Review

Sousa, A. D., Prabhu, A., & Matcheswalla, Y. (2010) · Journal of Pakistan Psychiatric Society

Further Investigation of Ketamine

Freedman, R. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050581 · Cited by 8 · see citing works

The Nature of Drug Dependence

Yates, W. R. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.3.407